  {"id":41572,"date":"2018-07-10T11:00:42","date_gmt":"2018-07-10T02:00:42","guid":{"rendered":"http:\/\/www.veeva.com\/jp\/?p=41572"},"modified":"2018-08-06T15:32:12","modified_gmt":"2018-08-06T06:32:12","slug":"new-clinical-studies-live-on-veeva-vault-edc","status":"publish","type":"post","link":"https:\/\/www.veeva.com\/jp\/news\/new-clinical-studies-live-on-veeva-vault-edc\/","title":{"rendered":"³Ô¹Ï±¬ÁÏ Vault EDC\u3067\u6700\u65b0\u306e\u81e8\u5e8a\u8a66\u9a13\u3092\u5b9f\u65bd"},"content":{"rendered":"<p style=\"text-align: right;\">2018\u5e747\u670810\u65e5<\/p>\n<p style=\"text-align: right;\">³Ô¹Ï±¬ÁÏ Japan\u682a\u5f0f\u4f1a\u793e<\/p>\n<p>&nbsp;<\/p>\n<p>³Ô¹Ï±¬ÁÏ Systems\u3010NYSE:VEEV\u3011(\u672c\u793e : \u30ab\u30ea\u30d5\u30a9\u30eb\u30cb\u30a2\u5dde\u30d7\u30ec\u30b6\u30f3\u30c8\u30f3\u3001\u65e5\u672c\u6cd5\u4eba \u672c\u793e : \u6771\u4eac\u90fd\u6e0b\u8c37\u533a\u3001\u65e5\u672c\u6cd5\u4eba\u4ee3\u8868\u53d6\u7de0\u5f79 : \u5ca1\u6751 \u5d07\u3001\u4ee5\u4e0b ³Ô¹Ï±¬ÁÏ)\u306f\u3001\u5927\u624b\u306e\u88fd\u85ac\u4f01\u696d\u304a\u3088\u3073CRO\u304c\u73fe\u5728\u3001\u81e8\u5e8a\u8a66\u9a13\u306b\u304a\u3051\u308b\u30c7\u30fc\u30bf\u30de\u30cd\u30b8\u30e1\u30f3\u30c8\u6539\u5584\u306b<strong><a href=\"https:\/\/www.veeva.com\/jp\/products\/vault-edc\/\">³Ô¹Ï±¬ÁÏ Vault EDC<\/a><\/strong>\u3092\u4f7f\u7528\u3057\u3066\u3044\u308b\u3053\u3068\u3092\u767a\u8868\u3057\u307e\u3057\u305f\u3002Vault EDC\u306f\u81e8\u5e8a\u8a66\u9a13\u3092\u3088\u308a\u8fc5\u901f\u306b\u69cb\u7bc9\u3057\u3001\u3088\u308a\u52b9\u679c\u7684\u306b\u5b9f\u65bd\u3059\u308b\u6700\u65b0\u3067\u67d4\u8edf\u306aEDC\u30bd\u30ea\u30e5\u30fc\u30b7\u30e7\u30f3\u3092\u63d0\u4f9b\u3057\u3066\u3044\u307e\u3059\u3002Vault EDC\u304c\u63d0\u4f9b\u958b\u59cb\u3055\u308c\u3066\u304b\u3089\u308f\u305a\u304b1\u5e74\u306e\u9593\u306b\u3001\u65e9\u671f\u63a1\u7528\u3057\u305f12\u306e\u4f01\u696d\u304c\u3053\u306e\u88fd\u54c1\u3092\u4f7f\u7528\u3057\u3066\u81e8\u5e8a\u8a66\u9a13\u3092\u958b\u59cb\u3057\u307e\u3057\u305f\u3002\u3053\u306e\u4e2d\u306b\u306f\u3001\u30b0\u30ed\u30fc\u30d0\u30eb\u88fd\u85ac\u4f01\u696d\u306e\u4e0a\u4f4d20\u793e\u306e\u3046\u3061\u306e1\u793e\u3082\u542b\u307e\u308c\u3066\u3044\u307e\u3059\u3002\u3059\u3067\u306b\u8907\u6570\u306e\u81e8\u5e8a\u8a66\u9a13\u304c\u5b9f\u65bd\u4e2d\u3067\u3001\u30aa\u30f3\u30b3\u30ed\u30b8\u30fc\u3001\u773c\u79d1\u3001\u533b\u7642\u6a5f\u5668\u3001\u5fc3\u81d3\u8840\u7ba1\u7cfb\u306a\u3069\u3001\u5e45\u5e83\u3044\u6cbb\u7642\u5206\u91ce\u306b\u308f\u305f\u3063\u3066Vault EDC\u304c\u4f7f\u7528\u3055\u308c\u3066\u3044\u307e\u3059\u3002(\u672c\u30ea\u30ea\u30fc\u30b9\u306f\u3001³Ô¹Ï±¬ÁÏ\u7c73\u56fd\u672c\u793e\u304c\u767a\u8868\u3057\u305f\u5831\u9053\u8cc7\u6599\u306e\u6284\u8a33\u3067\u3059)<\/p>\n<p>&nbsp;<\/p>\n<p>ICON\u793e\u3067\u30af\u30ea\u30cb\u30ab\u30eb\u30fb\u30ea\u30b9\u30af\u30fb\u30a2\u30f3\u30c9\u30fb\u30c7\u30fc\u30bf\u30de\u30cd\u30b8\u30e1\u30f3\u30c8\u62c5\u5f53\u30b7\u30cb\u30a2\u30f4\u30a1\u30a4\u30b9\u30d7\u30ec\u30b8\u30c7\u30f3\u30c8\u3092\u52d9\u3081\u3001³Ô¹Ï±¬ÁÏ Vault EDC\u3092\u6d3b\u7528\u3057\u3066\u81e8\u5e8a\u8a66\u9a13\u3092\u5b9f\u65bd\u3057\u3066\u3044\u308bAlison Liddy\u6c0f\u306f\u3001\u6b21\u306e\u3088\u3046\u306b\u8ff0\u3079\u3066\u3044\u307e\u3059\u3002\u300c\u81e8\u5e8a\u8a66\u9a13\u304c\u8907\u96d1\u3055\u3092\u5897\u3057\u3066\u3044\u308b\u4eca\u3001\u81e8\u5e8a\u8a66\u9a13\u30c7\u30fc\u30bf\u3092\u52b9\u7387\u7684\u306b\u7ba1\u7406\u3059\u308b\u6a5f\u80fd\u306f\u5fc5\u9808\u3067\u3059\u3002³Ô¹Ï±¬ÁÏ Vault EDC\u306f\u3001\u9ad8\u3044\u67d4\u8edf\u6027\u3092\u4fdd\u3061\u306a\u304c\u3089\u3001\u3088\u308a\u5bb9\u6613\u306b\u60a3\u8005\u30c7\u30fc\u30bf\u3092\u53ce\u96c6\u3067\u304d\u308b\u6b21\u4e16\u4ee3EDC\u3092\u63d0\u4f9b\u3057\u3066\u304f\u308c\u307e\u3059\u3002\u300d<\/p>\n<p>Vault EDC\u306e\u4f7f\u7528\u306b\u3088\u308a\u3001\u81e8\u5e8a\u8a66\u9a13\u30c7\u30fc\u30bf\u30de\u30cd\u30b8\u30e1\u30f3\u30c8\u30c1\u30fc\u30e0\u306e\u8a66\u9a13\u8a08\u753b\u306b\u8981\u3059\u308b\u6642\u9593\u304c\u77ed\u7e2e\u3055\u308c\u3001\u65e9\u3051\u308c\u30707\u9031\u9593\u3067\u81e8\u5e8a\u8a66\u9a13\u3092\u958b\u59cb\u3067\u304d\u308b\u3088\u3046\u306b\u306a\u308a\u307e\u3059\u3002\u81e8\u5e8a\u8a66\u9a13\u306e\u8a2d\u5b9a\u306b\u306f\u3001\u30c9\u30e9\u30c3\u30b0\u30a2\u30f3\u30c9\u30c9\u30ed\u30c3\u30d7\u30c4\u30fc\u30eb\u304c\u4f7f\u7528\u3055\u308c\u308b\u305f\u3081\u3001\u8907\u96d1\u306a\u30b3\u30fc\u30c9\u884c\u3092\u7de8\u96c6\u3059\u308b\u5fc5\u8981\u304c\u306a\u304f\u3001\u81e8\u5e8a\u8a66\u9a13\u7528\u30c7\u30fc\u30bf\u30d9\u30fc\u30b9\u3092\u69cb\u7bc9\u3059\u308b\u6642\u9593\u3092\u5927\u5e45\u306b\u524a\u6e1b\u3067\u304d\u307e\u3059\u3002\u307e\u305f\u3001Vault EDC\u306e\u5148\u9032\u7684\u306a\u30a2\u30fc\u30ad\u30c6\u30af\u30c1\u30e3\u3068\u4f7f\u3044\u3084\u3059\u304f\u76f4\u611f\u7684\u306a\u30a4\u30f3\u30bf\u30fc\u30d5\u30a7\u30fc\u30b9\u306b\u3088\u308a\u3001\u8a66\u9a13\u306e\u5909\u66f4\u7ba1\u7406\u304c\u7c21\u7d20\u5316\u3055\u308c\u308b\u305f\u3081\u3001\u79fb\u884c\u3084\u30c0\u30a6\u30f3\u30bf\u30a4\u30e0\u306b\u4f34\u3046\u30b3\u30b9\u30c8\u304c\u767a\u751f\u3059\u308b\u3053\u3068\u3082\u3042\u308a\u307e\u305b\u3093\u3002<\/p>\n<p><strong><a href=\"https:\/\/www.myeloma.org\/Black-Swan-Research-Initiative%E2%80%99s-ASCENT-Trial\">\u56fd\u969b\u9aa8\u9ac4\u816b\u8ca1\u56e3\uff08International Myeloma Foundation\uff09ASCENT<\/a><\/strong>\uff08Aggressive Smoldering Cure Evaluating Novel Rx Transplant\uff09\u306e\u81e8\u5e8a\u8a66\u9a13\u7ba1\u7406\u306b\u643a\u308f\u3063\u3066\u3044\u308b\u3001Trevie Research\u793e\u306e\u30d7\u30ec\u30b8\u30c7\u30f3\u30c8\u3001Robert Wittig\u6c0f\u306f\u6b21\u306e\u3088\u3046\u306b\u8ff0\u3079\u3066\u3044\u307e\u3059\u3002\u300c\u79c1\u305f\u3061\u306f\u3001\u30aa\u30f3\u30b3\u30ed\u30b8\u30fc\u5206\u91ce\u306e\u81e8\u5e8a\u8a66\u9a13\u4e2d\u306e\u30c7\u30fc\u30bf\u53ce\u96c6\u3084\u610f\u601d\u6c7a\u5b9a\u306b\u304a\u3044\u3066\u3001EDC\u30b7\u30b9\u30c6\u30e0\u306e\u8a2d\u5b9a\u3001\u30e1\u30f3\u30c6\u30ca\u30f3\u30b9\u3001\u67d4\u8edf\u6027\u304c\u975e\u5e38\u306b\u91cd\u8981\u3067\u3042\u308b\u3053\u3068\u3092\u8a8d\u8b58\u3057\u3066\u3044\u307e\u3059\u3002³Ô¹Ï±¬ÁÏ Vault EDC\u306f\u3001\u6700\u65b0\u3067\u9069\u5fdc\u6027\u306e\u3042\u308bEDC\u30af\u30e9\u30a6\u30c9\u30a2\u30d7\u30ea\u30b1\u30fc\u30b7\u30e7\u30f3\u3092\u63d0\u4f9b\u3057\u3001\u81e8\u5e8a\u8a66\u9a13\u306e\u30c7\u30fc\u30bf\u30de\u30cd\u30b8\u30e1\u30f3\u30c8\u306b\u304a\u3051\u308b\u30a4\u30ce\u30d9\u30fc\u30b7\u30e7\u30f3\u306e\u65b0\u6642\u4ee3\u3092\u78ba\u7acb\u3057\u3066\u3044\u307e\u3059\u3002\u300d<\/p>\n<p>³Ô¹Ï±¬ÁÏ\u306eVault EDC\u62c5\u5f53\u30f4\u30a1\u30a4\u30b9\u30d7\u30ec\u30b8\u30c7\u30f3\u30c8\u3001Richard Young\u306f\u6b21\u306e\u3088\u3046\u306b\u8ff0\u3079\u3066\u3044\u307e\u3059\u3002\u300c³Ô¹Ï±¬ÁÏ\u304c\u6700\u5927\u624b\u306e\u30e9\u30a4\u30d5\u30b5\u30a4\u30a8\u30f3\u30b9\u4f01\u696d\u5404\u793e\u3068\u9023\u643a\u3057\u3066\u3001\u81e8\u5e8a\u8a66\u9a13\u30c7\u30fc\u30bf\u30de\u30cd\u30b8\u30e1\u30f3\u30c8\u306e\u5408\u7406\u5316\u3068\u81e8\u5e8a\u8a66\u9a13\u5b9f\u65bd\u306e\u8fc5\u901f\u5316\u3092\u5b9f\u73fe\u3067\u304d\u308b\u306e\u306f\u5927\u5909\u5149\u6804\u306a\u3053\u3068\u3067\u3059\u3002\u3053\u306e\u696d\u754c\u306b\u6700\u65b0\u306eEDC\u30a2\u30d7\u30ea\u30b1\u30fc\u30b7\u30e7\u30f3\u3092\u63d0\u4f9b\u3057\u3001\u81e8\u5e8a\u8a66\u9a13\u306b\u304a\u3051\u308b\u30b9\u30d4\u30fc\u30c9\u3068\u30a2\u30b8\u30ea\u30c6\u30a3\u5411\u4e0a\u3092\u5b9f\u73fe\u3067\u304d\u308b\u3053\u3068\u3092\u5927\u5909\u559c\u3070\u3057\u304f\u601d\u3063\u3066\u3044\u307e\u3059\u3002\u300d<\/p>\n<p>Vault EDC\u306f\u3001<em>EDC<\/em><em>\u3001<\/em><em>CTMS<\/em><em>\u3001<\/em><em>eTMF<\/em><em>\u3001\u304a\u3088\u3073<\/em><em>Study Startup<\/em>\u3092\u3072\u3068\u3064\u306b\u307e\u3068\u3081\u305f<strong><a href=\"https:\/\/www.veeva.com\/jp\/products\/vault-clinical\/\">³Ô¹Ï±¬ÁÏ Vault Clinical Suite<\/a><\/strong>\u306e\u4e00\u90e8\u3067\u3001\u3053\u306e\u30b9\u30a4\u30fc\u30c8\u306f\u3001<strong><a href=\"https:\/\/www.veeva.com\/jp\/products\/clinical-data-management\/\">\u81e8\u5e8a\u8a66\u9a13\u30c7\u30fc\u30bf\u30de\u30cd\u30b8\u30e1\u30f3\u30c8<\/a><\/strong>\u3068<strong><a href=\"https:\/\/www.veeva.com\/jp\/products\/clinical-operations\/\">\u81e8\u5e8a\u8a66\u9a13\u30aa\u30da\u30ec\u30fc\u30b7\u30e7\u30f3<\/a><\/strong>\u3092\u5358\u4e00\u306e\u30af\u30e9\u30a6\u30c9\u30d7\u30e9\u30c3\u30c8\u30d5\u30a9\u30fc\u30e0\u4e0a\u306b\u7d71\u5408\u5316\u3057\u305f\u3082\u306e\u3067\u3059\u3002³Ô¹Ï±¬ÁÏ\u306e\u7d71\u5408\u30a2\u30d7\u30ea\u30b1\u30fc\u30b7\u30e7\u30f3\u30b9\u30a4\u30fc\u30c8\u306b\u3088\u308a\u3001\u5404\u8a66\u9a13\u30c1\u30fc\u30e0\u306f\u81e8\u5e8a\u8a66\u9a13\u306e\u30d7\u30ed\u30bb\u30b9\u3068\u60c5\u5831\u3092\u30b0\u30ed\u30fc\u30d0\u30eb\u3067\u307e\u3068\u3081\u3066\u78ba\u8a8d\u3059\u308b\u3053\u3068\u304c\u3067\u304d\u308b\u3088\u3046\u306b\u306a\u308a\u307e\u3059\u3002\u3053\u308c\u306b\u3088\u308a\u3001\u5404\u7d44\u7e54\u3067\u306f\u81e8\u5e8a\u8a66\u9a13\u306e\u30dd\u30fc\u30c8\u30d5\u30a9\u30ea\u30aa\u5168\u4f53\u3092\u5bb9\u6613\u306b\u7ba1\u7406\u3057\u3066\u3001\u81e8\u5e8a\u8a66\u9a13\u30d7\u30ed\u30bb\u30b9\u5168\u4f53\u3092\u6f0f\u308c\u306a\u304f\u5408\u7406\u5316\u3067\u304d\u308b\u3088\u3046\u306b\u306a\u308a\u307e\u3059\u3002<\/p>\n<p>³Ô¹Ï±¬ÁÏ\u306f\u3001<strong><a href=\"http:\/\/csdd.tufts.edu\/\">\u30bf\u30d5\u30c4\u533b\u85ac\u54c1\u958b\u767a\u7814\u7a76\u30bb\u30f3\u30bf\u30fc\uff08CSDD\uff09<\/a><\/strong>\u304c<strong><a href=\"http:\/\/www.veeva.com\/edc-survey\">2017 eClinical Landscape Study<\/a><\/strong>\u306e\u30d5\u30a9\u30ed\u30fc\u30a2\u30c3\u30d7\u8abf\u67fb\u3068\u3057\u3066\u884c\u3063\u305f\u3001\u81e8\u5e8a\u8a66\u9a13\u306e\u30b9\u30b1\u30b8\u30e5\u30fc\u30eb\u9045\u5ef6\u306b\u3064\u306a\u304c\u308b\u975e\u52b9\u7387\u306e\u6839\u672c\u7684\u306a\u539f\u56e0\u306b\u95a2\u3059\u308b\u7814\u7a76\u7d50\u679c\u306b\u3064\u3044\u3066\u3001\u6982\u8981\u306e\u516c\u958b\u3092\u767a\u8868\u3057\u307e\u3057\u305f\u3002\u8a73\u7d30\u306f\u3001\u5f0a\u793e\u306e<strong><a href=\"https:\/\/www.veeva.com\/jp\/news\/clinical-data-management-leaders-reveal-underlying-challenges-impacting-trial-timelines\/\">\u30d7\u30ec\u30b9\u30ea\u30ea\u30fc\u30b9<\/a><\/strong>\u3092\u3054\u89a7\u304f\u3060\u3055\u3044\u3002<\/p>\n<p>\u307e\u305f\u3001\u898f\u6a21\u304c\u62e1\u5927\u3057\u7d9a\u3051\u308b³Ô¹Ï±¬ÁÏ\u81e8\u5e8a\u8a66\u9a13\u30c7\u30fc\u30bf\u30de\u30cd\u30b8\u30e1\u30f3\u30c8\u30b3\u30df\u30e5\u30cb\u30c6\u30a3\u306b\u3054\u53c2\u52a0\u304f\u3060\u3055\u3044\u3002³Ô¹Ï±¬ÁÏ\u3068\u5f0a\u793e\u306e\u81e8\u5e8a\u8a66\u9a13\u30d1\u30fc\u30c8\u30ca\u30fc\u306e\u8a73\u7d30\u306b\u3064\u3044\u3066\u306f\u30019\u670816\u65e5\uff5e18\u65e5\u306b\u7c73\u56fd\u30d5\u30a3\u30e9\u30c7\u30eb\u30d5\u30a3\u30a2\u3067\u958b\u50ac\u3055\u308c\u308b<strong><a href=\"https:\/\/www.veeva.com\/events\/rd-summit\/\">³Ô¹Ï±¬ÁÏ R&amp;D Summit<\/a><\/strong>\u3067\u3054\u78ba\u8a8d\u304f\u3060\u3055\u3044\u3002<\/p>\n<p>&nbsp;<\/p>\n<p><strong>\u3010\u30bf\u30d5\u30c4\u533b\u85ac\u54c1\u958b\u767a\u7814\u7a76\u30bb\u30f3\u30bf\u30fc\u306b\u3064\u3044\u3066\u3011<\/strong><br \/>\n\u30bf\u30d5\u30c4\u5927\u5b66\u306e\u30bf\u30d5\u30c4\u533b\u85ac\u54c1\u958b\u767a\u7814\u7a76\u30bb\u30f3\u30bf\u30fc\u306f\u3001\u533b\u85ac\u54c1\u306e\u958b\u767a\u3001\u898b\u76f4\u3057\u3001\u5229\u7528\u306e\u8cea\u3068\u52b9\u7387\u306e\u6539\u5584\u306b\u5f79\u7acb\u3064\u6226\u7565\u7684\u60c5\u5831\u3092\u533b\u85ac\u54c1\u958b\u767a\u4f01\u696d\u3001\u898f\u5236\u5f53\u5c40\u3001\u653f\u7b56\u7acb\u6848\u8005\u306b\u63d0\u4f9b\u3057\u3066\u3044\u307e\u3059\u3002\u30dc\u30b9\u30c8\u30f3\u3092\u62e0\u70b9\u3068\u3059\u308b\u30bf\u30d5\u30c4\u533b\u85ac\u54c1\u958b\u767a\u7814\u7a76\u30bb\u30f3\u30bf\u30fc\u306f\u3001\u533b\u85ac\u54c1\u306b\u95a2\u3059\u308b\u554f\u984c\u306e\u5e45\u5e83\u304f\u8a73\u7d30\u306a\u5206\u6790\u3001\u30b7\u30f3\u30dd\u30b8\u30a6\u30e0\u3001\u30ef\u30fc\u30af\u30b7\u30e7\u30c3\u30d7\u3001\u30d1\u30d6\u30ea\u30c3\u30af\u30d5\u30a9\u30fc\u30e9\u30e0\u306e\u4e3b\u50ac\u3001\u30bf\u30d5\u30c4\u533b\u85ac\u54c1\u958b\u767a\u7814\u7a76\u30bb\u30f3\u30bf\u30fc\u5f71\u97ff\u5831\u544a\u66f8\u306e\u767a\u8868\u3001\u9694\u6708\u30cb\u30e5\u30fc\u30b9\u30ec\u30bf\u30fc\u306e\u767a\u884c\u306a\u3069\u3001\u91cd\u8981\u306a\u533b\u85ac\u54c1\u958b\u767a\u306e\u554f\u984c\u306e\u5206\u6790\u3068\u77e5\u898b\u3092\u63d0\u4f9b\u3057\u307e\u3059\u3002\u8a73\u7d30\u306b\u3064\u3044\u3066\u306f<a href=\"http:\/\/csdd.tufts.edu\/\">http:\/\/csdd.tufts.edu<\/a>\u3092\u3054\u89a7\u304f\u3060\u3055\u3044\u3002<\/p>\n<p><strong>\u3010³Ô¹Ï±¬ÁÏ Systems\u793e\u306b\u3064\u3044\u3066\u3011<br \/>\n<\/strong>³Ô¹Ï±¬ÁÏ Systems\u793e\u306f\u30b0\u30ed\u30fc\u30d0\u30eb\u306a\u30e9\u30a4\u30d5\u30b5\u30a4\u30a8\u30f3\u30b9\u4f01\u696d\u3084\u305d\u306e\u4ed6\u306e\u898f\u5236\u3092\u53d7\u3051\u308b\u88fd\u9020\u696d\u8005\u5411\u3051\u306b\u3001\u30af\u30e9\u30a6\u30c9\u30d9\u30fc\u30b9\u306e\u30bd\u30d5\u30c8\u30a6\u30a7\u30a2\u3092\u63d0\u4f9b\u3059\u308b\u30ea\u30fc\u30c7\u30a3\u30f3\u30b0\u30ab\u30f3\u30d1\u30cb\u30fc\u3067\u3059\u3002\u4e16\u754c\u6700\u5927\u898f\u6a21\u306e\u88fd\u85ac\u4f1a\u793e\u304b\u3089\u30d0\u30a4\u30aa\u30c6\u30af\u30ce\u30ed\u30b8\u30fc\u5206\u91ce\u306e\u65b0\u8208\u4f01\u696d\u307e\u3067625\u793e\u3092\u8d85\u3048\u308b\u9867\u5ba2\u3092\u64c1\u3057\u3001\u6280\u8853\u9769\u65b0\u3078\u306e\u53d6\u308a\u7d44\u307f\u3084\u5353\u8d8a\u3057\u305f\u88fd\u54c1\u529b\u306b\u3088\u3063\u3066\u3001\u304a\u5ba2\u69d8\u306e\u6210\u529f\u3092\u30b5\u30dd\u30fc\u30c8\u3057\u3066\u3044\u307e\u3059\u3002³Ô¹Ï±¬ÁÏ\u306f\u3001\u30b5\u30f3\u30d5\u30e9\u30f3\u30b7\u30b9\u30b3\u306e\u30d9\u30a4\u30a8\u30ea\u30a2\u306b\u672c\u793e\u3092\u7f6e\u304d\u3001\u30e8\u30fc\u30ed\u30c3\u30d1\u3001\u30a2\u30b8\u30a2\u3001\u30e9\u30c6\u30f3\u30a2\u30e1\u30ea\u30ab\u306b\u62e0\u70b9\u3092\u5c55\u958b\u3057\u3066\u3044\u307e\u3059\u3002\u8a73\u3057\u304f\u306f\u3001<strong><a href=\"https:\/\/veeva.com\/jp\/\" target=\"_blank\" rel=\"noopener noreferrer\">\u516c\u5f0f\u30b5\u30a4\u30c8<\/a><\/strong>\u3092\u3054\u89a7\u304f\u3060\u3055\u3044\u3002<\/p>\n<p><strong>\u3010Forward-looking Statements\u3011<\/strong><br \/>\nThis release contains forward-looking statements, including the market demand for and acceptance of ³Ô¹Ï±¬ÁÏ\u2019s products and services, the results from use of ³Ô¹Ï±¬ÁÏ\u2019s products and services, and general business conditions, particularly in the life sciences industry. Any forward-looking statements contained in this press release are based upon ³Ô¹Ï±¬ÁÏ\u2019s historical performance and its current plans, estimates, and expectations, and are not a representation that such plans, estimates, or expectations will be achieved. These forward-looking statements represent ³Ô¹Ï±¬ÁÏ\u2019s expectations as of the date of this press announcement. Subsequent events may cause these expectations to change, and ³Ô¹Ï±¬ÁÏ disclaims any obligation to update the forward-looking statements in the future. These forward-looking statements are subject to known and unknown risks and uncertainties that may cause actual results to differ materially. Additional risks and uncertainties that could affect ³Ô¹Ï±¬ÁÏ\u2019s financial results are included under the captions, \u201cRisk Factors\u201d and \u201cManagement\u2019s Discussion and Analysis of Financial Condition and Results of Operations,\u201d in the company\u2019s filing on Form 10-Q for the period ended April\u00a030, 2018. This is available on the company\u2019s website at <a href=\"https:\/\/www.veeva.com\/\">www.veeva.com<\/a> under the Investors section and on the SEC\u2019s website at <a href=\"http:\/\/www.sec.gov\/\">www.sec.gov<\/a>. Further information on potential risks that could affect actual results will be included in other filings ³Ô¹Ï±¬ÁÏ makes with the SEC from time to time.<\/p>\n","protected":false},"excerpt":{"rendered":"<p>2018\u5e747\u670810\u65e5 ³Ô¹Ï±¬ÁÏ Japan\u682a\u5f0f\u4f1a\u793e &nbsp; ³Ô¹Ï±¬ÁÏ Systems\u3010NYSE:VEEV\u3011(\u672c\u793e : \u30ab\u30ea\u30d5\u30a9\u30eb\u30cb\u30a2\u5dde\u30d7\u30ec\u30b6\u30f3\u30c8\u30f3\u3001\u65e5\u672c\u6cd5\u4eba \u672c\u793e : \u6771\u4eac\u90fd\u6e0b\u8c37\u533a\u3001\u65e5\u672c\u6cd5\u4eba\u4ee3\u8868\u53d6\u7de0\u5f79 : \u5ca1\u6751&hellip;<\/p>\n","protected":false},"author":131,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[322],"tags":[],"class_list":["post-41572","post","type-post","status-publish","format-standard","hentry","category-press-release"],"acf":[],"aioseo_notices":[],"_links":{"self":[{"href":"https:\/\/www.veeva.com\/jp\/wp-json\/wp\/v2\/posts\/41572"}],"collection":[{"href":"https:\/\/www.veeva.com\/jp\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.veeva.com\/jp\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.veeva.com\/jp\/wp-json\/wp\/v2\/users\/131"}],"replies":[{"embeddable":true,"href":"https:\/\/www.veeva.com\/jp\/wp-json\/wp\/v2\/comments?post=41572"}],"version-history":[{"count":6,"href":"https:\/\/www.veeva.com\/jp\/wp-json\/wp\/v2\/posts\/41572\/revisions"}],"predecessor-version":[{"id":41718,"href":"https:\/\/www.veeva.com\/jp\/wp-json\/wp\/v2\/posts\/41572\/revisions\/41718"}],"wp:attachment":[{"href":"https:\/\/www.veeva.com\/jp\/wp-json\/wp\/v2\/media?parent=41572"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.veeva.com\/jp\/wp-json\/wp\/v2\/categories?post=41572"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.veeva.com\/jp\/wp-json\/wp\/v2\/tags?post=41572"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}